Dose-finding and -expansion studies of trastuzumab deruxtecan in combination with other anti-cancer agents in patients (pts) with advanced/metastatic HER2+ (DESTINY-Breast07 [DB-07]) and HER2-low (DESTINY-Breast08 [DB-08]) breast cancer (BC) Meeting Abstract
| Authors: | Andre, F.; Hamilton, E. P.; Loi, S.; Im, S. A.; Sohn, J.; Tseng, L. M.; Anders, C. K.; Schmid, P.; Boston, S.; Darilay, A.; Herbolsheimer, P. M.; Konpa, A.; Patel, G.; Yu, T.; Wrona, M.; Jhaveri, K. L. |
| Abstract Title: | Dose-finding and -expansion studies of trastuzumab deruxtecan in combination with other anti-cancer agents in patients (pts) with advanced/metastatic HER2+ (DESTINY-Breast07 [DB-07]) and HER2-low (DESTINY-Breast08 [DB-08]) breast cancer (BC) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300918 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.3025 |
| Notes: | Meeting Abstract: 3025 -- This meeting was also held virtually -- Source: Wos |
